{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:41:22Z","timestamp":1789184482700,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1071735"],"award-info":[{"award-number":["APP1071735"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1147-2","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T03:55:57Z","timestamp":1477108557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The association of low complement with disease activity in systemic sclerosis: a prospective cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"James","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Sahhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Rabusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Zochling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna M.","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,22]]},"reference":[{"issue":"6","key":"1147_CR1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.berh.2010.10.007","volume":"24","author":"M Nikpour","year":"2010","unstructured":"Nikpour M, Stevens WM, Herrick AL, Proudman SM. Epidemiology of systemic sclerosis. Best Pract Res Clin Rheumatol. 2010;24(6):857\u201369.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"19","key":"1147_CR2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989\u20132003.","journal-title":"N Engl J Med"},{"issue":"2","key":"1147_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-857X(03)00023-1","volume":"29","author":"TA Medsger Jr","year":"2003","unstructured":"Medsger Jr TA. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am. 2003;29(2):255\u201373.","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"1147_CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0950-3579(05)80190-6","volume":"9","author":"DPM Symmons","year":"1995","unstructured":"Symmons DPM. Disease assessment indexes: activity, damage and severity. Baillieres Clin Rheumatol. 1995;9(2):267\u201385.","journal-title":"Baillieres Clin Rheumatol"},{"issue":"2","key":"1147_CR5","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol. 2002;29(2):288\u201391.","journal-title":"J Rheumatol"},{"issue":"3 Suppl 29","key":"1147_CR6","first-page":"S39","volume":"21","author":"G Valentini","year":"2003","unstructured":"Valentini G, Silman AJ, Veale D. Assessment of disease activity. Clin Exp Rheumatol. 2003;21(3 Suppl 29):S39\u201341.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"1147_CR7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/ard.60.6.585","volume":"60","author":"A Della Rossa","year":"2001","unstructured":"Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman AJ, D\u2019Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis. 2001;60(6):585\u201391.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1147_CR8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","volume":"60","author":"G Valentini","year":"2001","unstructured":"Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D\u2019Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis. 2001;60(6):592\u20138.","journal-title":"Ann Rheum Dis"},{"key":"1147_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/03009749209095054","volume":"21","author":"A Scheja","year":"1992","unstructured":"Scheja A, Akesson A, Horslev-Petersen K. Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis. Scand J Rheumatol. 1992;21:5\u20139.","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"1147_CR10","first-page":"646","volume":"23","author":"VD Steen","year":"1996","unstructured":"Steen VD, Engel EE, Charley MR, Medsger Jr TA. Soluble serum interleukin 2 receptors in patients with systemic sclerosis. J Rheumatol. 1996;23(4):646\u20139.","journal-title":"J Rheumatol"},{"key":"1147_CR11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1655973","volume":"77","author":"U Vischer","year":"1997","unstructured":"Vischer U, Ingerslev J, Wollheim C, Mestries JC, Tsakiris D, Haefeli W, et al. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) levels. Thromb Haemost. 1997;77:387\u201393.","journal-title":"Thromb Haemost"},{"issue":"7","key":"1147_CR12","first-page":"908","volume":"17","author":"PJ Clements","year":"1990","unstructured":"Clements PJ, Peter JB, Agopian MS, Telian NS, Furst DE. Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil. J Rheumatol. 1990;17(7):908\u201310.","journal-title":"J Rheumatol"},{"issue":"10","key":"1147_CR13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/rheumatology\/31.10.683","volume":"31","author":"W Stevens","year":"1992","unstructured":"Stevens W, Vancheeswaran R. Black CM; UK Systemic Sclerosis Study Group. Alpha interferon-2a (Roferon-A) in the treatment of diffuse cutaneous systemic sclerosis: a pilot study. Br J Rheumatol. 1992;31(10):683\u20139.","journal-title":"Br J Rheumatol"},{"issue":"3","key":"1147_CR14","doi-asserted-by":"crossref","first-page":"J276","DOI":"10.1016\/j.jaut.2009.11.014","volume":"34","author":"M Chen","year":"2010","unstructured":"Chen M, Daha MR, Kallenberg CGM. The complement system in systemic autoimmune disease. J Autoimmun. 2010;34(3):J276\u201386.","journal-title":"J Autoimmun"},{"issue":"8","key":"1147_CR15","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/art.1780280810","volume":"28","author":"RM Valentijn","year":"1985","unstructured":"Valentijn RM, van Overhagen H, Hazevoet HM, Hermans J, Cats A, Daha MR, et al. The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 1985;28(8):904\u201313.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1147_CR16","first-page":"75","volume":"75","author":"G Sturfelt","year":"1984","unstructured":"Sturfelt G, Sjoholm AG. Complement components, complement activation, and acute phase response in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 1984;75(1):75\u201383.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1147_CR17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11926-014-0474-z","volume":"17","author":"S Bhattacharyya","year":"2015","unstructured":"Bhattacharyya S, Varga J. Emerging roles of innate immune signaling and Toll-like receptors in fibrosis and systemic sclerosis. Curr Rheumatol Rep. 2015;17(1):474.","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"1147_CR18","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737\u201347.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1147_CR19","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger Jr TA. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28(7):1573\u20136.","journal-title":"J Rheumatol"},{"issue":"7","key":"1147_CR20","first-page":"1281","volume":"22","author":"P Clements","year":"1995","unstructured":"Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22(7):1281\u20135.","journal-title":"J Rheumatol"},{"issue":"1","key":"1147_CR21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/AAP.0b013e31823ebc74","volume":"37","author":"Y Ma","year":"2012","unstructured":"Ma Y, Mazumdar M, Memtsoudis SG. Beyond repeated-measures analysis of variance: advanced statistical methods for the analysis of longitudinal data in anesthesia research. Reg Anesth Pain Med. 2012;37(1):99\u2013105.","journal-title":"Reg Anesth Pain Med"},{"issue":"4","key":"1147_CR22","first-page":"268","volume":"60","author":"G Cuomo","year":"2008","unstructured":"Cuomo G, Abignano G, Ruocco L, Vettori S, Valentini G. Hypocomplementemia in systemic sclerosis [in Italian]. Reumatismo. 2008;60(4):268\u201373.","journal-title":"Reumatismo"},{"issue":"11","key":"1147_CR23","first-page":"2218","volume":"34","author":"M Hudson","year":"2007","unstructured":"Hudson M, Walker JG, Fritzler M, Taillefer S, Baron M. Hypocomplementemia in systemic sclerosis - clinical and serological correlations. J Rheumatol. 2007;34(11):2218\u201323.","journal-title":"J Rheumatol"},{"issue":"10","key":"1147_CR24","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/anr.1780321011","volume":"32","author":"G Senaldi","year":"1989","unstructured":"Senaldi G, Lupoli S, Vergani D, Black CM. Activation of the complement system in systemic sclerosis: relationship to clinical severity. Arthritis Rheum. 1989;32(10):1262\u20137.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1147_CR25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","volume":"40","author":"I Batal","year":"2009","unstructured":"Batal I, Domsic RT, Shafer A, Medsger Jr TA, Kiss LP, Randhawa P, et al. Renal biopsy findings predicting outcome in scleroderma renal crisis. Hum Pathol. 2009;40(3):332\u201340.","journal-title":"Hum Pathol"},{"issue":"9","key":"1147_CR26","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/ard.62.9.901","volume":"62","author":"G Valentini","year":"2003","unstructured":"Valentini G, Bencivelli W, Bombardieri S, D\u2019Angelo S, Della Rossa A, Silman AJ, et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis. 2003;62(9):901\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1147_CR27","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/ard.62.9.904","volume":"62","author":"G Valentini","year":"2003","unstructured":"Valentini G, D\u2019Angelo S, Della Rossa A, Bencivelli W, Bombardieri S. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis. 2003;62(9):904\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1147_CR28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s10157-012-0700-9","volume":"17","author":"J Yuan","year":"2013","unstructured":"Yuan J, Chen M, Zhao MH. Complement in antineutrophil cytoplasmic antibody-associated vasculitis. Clin Exp Nephrol. 2013;17(5):642\u20135.","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"1147_CR29","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/acr.21716","volume":"64","author":"C Muangchan","year":"2012","unstructured":"Muangchan C, Harding S, Khimdas S, Bonner A, Group CSR, Baron M, Pope J. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group. Arthritis Care Res (Hoboken). 2012;64(9):1405\u201314.","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1147-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T18:53:18Z","timestamp":1568487198000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1147-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,22]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1147-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,22]]},"article-number":"246"}}